Clinical Trials Browser

INDUSTRY × Lymphoma × BAY 1895344 × Clear all

NCT03188965 2023-10-11

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Phase 1 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell